Molecure S.A. (MOC.WA)

PLN 10.0

(-1.96%)

Revenue Summary of Molecure S.A.

Molecure S.A.'s latest annual revenue in 2023 was 100.00 PLN , down -99.99% from previous year.
Molecure S.A.'s latest quarterly revenue in 2024 Q3 was - PLN , down -100.0% from previous quarter.
Molecure S.A. reported a annual revenue of 1.61 Million PLN in annual revenue 2022, up 403209.5% from previous year.
Molecure S.A. reported a annual revenue of 400.00 PLN in annual revenue 2021, down -100.0% from previous year.
Molecure S.A. reported a quarterly revenue of 13.94 Thousand PLN for 2024 Q2, down -50.98% from previous quarter.
Molecure S.A. reported a quarterly revenue of 28.43 Thousand PLN for 2024 Q1, down -98.82% from previous quarter.

Annual Revenue Chart of Molecure S.A. (2023 - 2015)

Historical Annual Revenue of Molecure S.A. (2023 - 2015)

Year	Revenue	Revenue Growth
2023	100.00 PLN	-99.99%
2022	1.61 Million PLN	403209.5%
2021	400.00 PLN	-100.0%
2020	122.93 Million PLN	4379536.62%
2019	2807.00 PLN	-6.43%
2018	3000.00 PLN	-50.0%
2017	6000.00 PLN	-9.09%
2016	6600.00 PLN	22.22%
2015	5400.00 PLN	0.0%

Year	Revenue	Revenue Growth
2024 Q3	- PLN	-100.0%
2024 Q2	13.94 Thousand PLN	-50.98%
2024 Q1	28.43 Thousand PLN	-98.82%
2023 Q2	19.02 Thousand PLN	-98.05%
2023 FY	100.00 PLN	-99.99%
2023 Q3	247.89 Thousand PLN	1203.22%
2023 Q4	2.42 Million PLN	876.22%
2023 Q1	976.83 Thousand PLN	582.2%
2022 Q2	259.37 Thousand PLN	-73.63%
2022 Q4	143.18 Thousand PLN	-36.92%
2022 FY	1.61 Million PLN	403209.5%
2022 Q1	983.67 Thousand PLN	92.99%
2022 Q3	227 Thousand PLN	-12.48%
2021 Q4	509.71 Thousand PLN	159.27%
2021 FY	400.00 PLN	-100.0%
2021 Q3	196.59 Thousand PLN	8548.6%
2021 Q2	-2327.00 PLN	-185.33%
2021 Q1	2727.00 PLN	-100.0%
2020 Q2	555.45 Thousand PLN	47.53%
2020 Q3	337.00 PLN	-99.94%
2020 Q4	122.93 Million PLN	36479443.92%
2020 FY	122.93 Million PLN	4379536.62%
2020 Q1	376.49 Thousand PLN	75199.2%
2019 Q1	1052.00 PLN	157.52%
2019 Q4	500.00 PLN	-50.0%
2019 Q3	1000.00 PLN	292.16%
2019 Q2	255.00 PLN	-75.76%
2019 FY	2807.00 PLN	-6.43%
2018 Q4	-1829.00 PLN	-200.0%
2018 Q2	2000.00 PLN	100.0%
2018 Q1	1000.00 PLN	-33.33%
2018 FY	3000.00 PLN	-50.0%
2018 Q3	1829.00 PLN	-8.55%
2017 Q1	2000.00 PLN	100.0%
2017 Q4	1500.00 PLN	-40.0%
2017 FY	6000.00 PLN	-9.09%
2017 Q3	2500.00 PLN	-99.19%
2017 Q2	308.12 Thousand PLN	15306.0%
2016 Q3	1000.00 PLN	-99.39%
2016 Q4	1000.00 PLN	0.0%
2016 FY	6600.00 PLN	22.22%
2016 Q1	163.41 Thousand PLN	0.0%
2016 Q2	163.41 Thousand PLN	0.0%
2015 FY	5400.00 PLN	0.0%

Peer Revenue Comparison of Molecure S.A.

Name	Revenue	Revenue Difference
Bioceltix S.A.	- PLN	-Infinity%
BIOTON S.A.	181.63 Million PLN	100.0%
Captor Therapeutics Spolka Akcyjna	13.2 Million PLN	99.999%
Mabion S.A.	151.67 Million PLN	100.0%
NanoGroup S.A.	2019.00 PLN	95.047%
Pharmena S.A.	9.83 Million PLN	99.999%
Poltreg S.A.	1.39 Million PLN	99.993%
Pure Biologics Spólka Akcyjna	95 Thousand PLN	99.895%
Ryvu Therapeutics S.A.	46.86 Million PLN	100.0%
Synthaverse S.A.	58.6 Million PLN	100.0%
Urteste S.A.	- PLN	-Infinity%